Abstract
Parathyroid carcinoma is a rare malignancy that is responsible for only 0.5 to 4% of all cases of primary hyperparathyroidism. Surgery is the only curative treatment. We report a case of a 46-year-old woman referred for a severe osteoporosis with frequent bone fracture associated with hypercalcemia. Initially, though she had multiple osteolytic lesions, we thought that the lesions were brown tumors resulting from hyperparathyroidism. The patient underwent surgery and was diagnosed with parathyroid carcinoma. After surgery, her intact PTH level normalized for brief period of time, but it was again elevated at 6 weeks after surgery. We suggest that the multiple osteolytic lesions were metastases because there was no evidence of local recurrence of parathyroid carcinoma, and the lesions looked like metastases on CT and PET-CT. The patient was treated with radiation therapy on the lumbar vertebra, one a site of the metastatic lesions. After radiotherapy, her serum intact PTH was decreased.
References
1. Ruda JM, Hollenbeak CS, Stack BC Jr. A systematic review of the diagnosis and treatment of primary hyperparathyroidism from 1995 to 2003. Otolaryngol Head Neck Surg. 2005. 132:359–372.
2. Wynne AG, Van Heerden J, Carney JA, Fitzpatrick LA. Parathyroid carcinoma: clinical and pathologic features in 43 patients. Medicine. 1992. 71:197–205.
3. Choi YK, Lee JS, Kim HW, Kim YM, Son SM, Kim IJ, Kim YK, Chae HJ. A case of parathyroid carcinoma invading thyroid gland as solitary nodular form. J Kor Soc Endocrinol. 1999. 14:171–176.
4. Kang MS, Lee HY, Seo PJ, Seo HJ, Kwon MS. A case of ectopic parathyroid carcinoma presenting with renal failure and anemia. Kor J Intern Med. 2006. 71:435–441.
5. Rao SR, Shaha AR, Singh B, Rinaldo A, Ferlito A. Management of cancer of the parathyroid. Acta Otolaryngol. 2002. 122:448–452.
6. Hundahl SA, Fleming ID, Fremgen AM, Menck HR. Two hundred eighty-six cases of parathyroid carcinoma treated in the U.S. between 1985-1995: A National Cancer Data Base report. Cancer. 1999. 86:538–544.
7. Shane E. Clinical review 122: parathyroid carcinoma. J Clin Endocrinol Metab. 2001. 86:485–493.
8. Kebebew E. Parathyroid carcinoma. Curr Treat Options Oncol. 2001. 2:347–354.
9. Clayman GL, Gonzalez HE, El-Naggar A, Vassilopoulou-Sellin R. Parathyroid carcinoma: evaluation and Interdisciplinary Management. Cancer. 2004. 100:900–905.
10. Munson ND, Foote RL, Northcutt RC, Tiegs RD, Fitzpatrick LA, Grant CS, Van Heerden JA, Thompson GB, Lloyd RV. Parathyroid carcinoma: is there a role for adjuvant radiation therapy? Cancer. 2003. 98:2378–2384.
11. Brandi ML, Gagel RF, Angeli A, Bilezikian JP, Beck-Peccoz P, Bordi C, Conte-Devolx B, Falchetti A, Gheri RG, Libroia A, Lips CJ, Lombardi G, Mannelli M, Pacini F, Ponder BA, Raue F, Skogseid B, Tamburrano G, Thakker RV, Thompson NW, Tomassetti P, Tonelli F, Wells SA Jr, Marx SJ. Guidelines for diagnosis and therapy of MEN type 1 and type 2. J Clin Endocrinol Metab. 2001. 86:5658–5671.
12. Favia G, Lumachi F, Polistina F, D'Amico DF. Parathyroid carcinoma: sixteen new cases and suggestions for correct management. World J Surg. 1998. 22:1225–1230.
13. Kleinpeter KP, Lovato JF, Clark PB, Wooldridge T, Norman ES, Bergman S, Perrier ND. Is parathyroid carcinoma indeed a lethal disease? Ann Surg Oncol. 2005. 12:260–266.
14. Ryu CS, Kim DK, Park KH, Seong SG, Kim DH, Woo SM, Cho IS. A case of primary parathyroid carcinoma with full-brown symptom. J Kor Soc Endocrinol. 1996. 11:221–226.
15. Grimelius L, Johansson H. Pathology of parathyroid tumors. Semin Surg Oncol. 1997. 13:142–154.
16. Koea JB, Shaw JH. Parathyroid cancer: Biology and management. Surg Oncol. 1999. 8:155–165.
17. Oh SK, Park YH, Kim JH, Lee MS, Min HK. Multiple primary parathyroid carcinoma. J Kor Surg Soc. 1990. 39:546–553.
18. Pai M, Park CH, Kim BS, Chung YS, Park HB. Multiple brown tumors in parathyroid carcinoma mimicking metastatic bone disease. Clin Nucl Med. 1997. 22:691–694.
19. Rasmuson T, Kristoffersson A, Boquist L. Positive effect of radiotherapy and surgery on hormonally active pulmonary metastases of primary parathyroid carcinoma. Eur J Endocrinol. 2000. 143:749–754.
20. Bukowski RM, Sheeler L, Cunningham J, Esselstyn C. Successful combination chemotherapy for metastatic parathyroid carcinoma. Arch Intern Med. 1984. 144:399–400.